E2F1 and Hepatic fibrosis: We observed a similar elevation of the E2F1 protein in the liver of TAA‐injected Chrebpα‐LKO mice (Figure 6C right bottom panel), in support of ChREBPα as a negative regulator of E2F1 in liver fibrosis.